Onchilles Pharma, a pioneering biotech firm specializing in cancer treatments harnessing a unique innate immune approach for targeted and potent tumor eradication, revealed groundbreaking preclinical findings today. The data pertained to N17465 administered systemically, presented orally, and N17350 directed at…
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a prominent RNAi therapeutics firm, has unveiled encouraging outcomes from the KARDIA-2 Phase 2 trial. This study assessed the effectiveness and safety of a single subcutaneous dose of zilebesiran alongside one of three standard antihypertensive…
Edgewood Oncology, a biotech company specializing in BTX-A51 treatments for hematologic malignancies and solid tumors, has revealed fresh preclinical findings. The study, conducted by Dana-Farber Cancer Institute and Hebrew University-Hadassah Medical School, explores BTX-A51’s potential in human liposarcoma (LPS). These…
During the 39th European Association of Urology Congress (EAU), Quanta System solidifies its position as a global leader in laser manufacturing, introducing a groundbreaking solution for stone treatment: Quanta Magneto Technology™. This innovation marks a significant advancement in urological care…
Johnson & Johnson (NYSE: JNJ) and Shockwave Medical, Inc. (Nasdaq: SWAV) have announced a definitive agreement for Johnson & Johnson to acquire all outstanding shares of Shockwave for $335.00 per share in cash, representing an enterprise value of approximately $13.1…
Natera, a leader in cell-free DNA testing, presents findings from the IMvigor011 study at the EAU Congress 2024. The analysis focuses on muscle-invasive bladder cancer (MIBC) patients who tested negative with Signatera™, Natera’s molecular residual disease (MRD) test. IMvigor011, sponsored…
Nucleai, a leader in spatial AI biomarkers, will present pioneering advancements in cancer diagnostics at the AACR Annual Meeting. Their posters will introduce novel AI spatial biomarkers and enhanced histopathology workflows poised to transform cancer treatment. One poster, developed with…
Cardinal Health’s U.S. medical products distribution division proudly announced today that it has been honored with the HIRC Resiliency Partner Badge, achieving a prestigious Diamond-level rating for outstanding performance in supply chain resilience maturity. The HIRC’s Resiliency Badge program, recognized…
Today, Cardinal Health (NYSE: CAH) announced the commencement of construction for a new 350,000 square-foot logistics center in Columbus, Ohio. This center will serve as a centralized replenishment hub for distributing over-the-counter consumer health products in support of its core…
Oklahoma Complete Health, a subsidiary of Centene Corporation, is now extending healthcare solutions to eligible SoonerSelect members in Oklahoma. The transition period for SoonerSelect members to switch to Oklahoma Complete Health or the Children’s Specialty Program lasts until July 1,…
Siemens Healthineers and Sysmex Corporation have initiated the separate distribution of their combined wide hemostasis testing solutions to laboratories across the United States and Europe. This move aims to provide healthcare providers with simplified access to leading hemostasis testing solutions,…
Today, CVS Health® (NYSE: CVS) unveiled two initiatives aimed at assisting pharmacy students: an upgraded PharmD tuition aid program for eligible CVS Pharmacy® interns and a new scholarship for students enrolled in pharmacy schools across the country. The enhanced CVS…